nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
|
Beatty, Gregory L. |
|
2016 |
166 |
C |
p. 30-39 10 p. |
artikel |
2 |
Cortisol and CBG — Getting cortisol to the right place at the right time
|
Henley, David |
|
2016 |
166 |
C |
p. 128-135 8 p. |
artikel |
3 |
Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease
|
Passey, Samantha L. |
|
2016 |
166 |
C |
p. 56-70 15 p. |
artikel |
4 |
Immune suppressive properties of artemisinin family drugs
|
Hou, Lifei |
|
2016 |
166 |
C |
p. 123-127 5 p. |
artikel |
5 |
Microglia activation states and cannabinoid system: Therapeutic implications
|
Mecha, M. |
|
2016 |
166 |
C |
p. 40-55 16 p. |
artikel |
6 |
Mitochondria dysfunction: A novel therapeutic target in pathological lung remodeling or bystander?
|
Rowlands, David J. |
|
2016 |
166 |
C |
p. 96-105 10 p. |
artikel |
7 |
Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders
|
Ganai, Shabir Ahmad |
|
2016 |
166 |
C |
p. 106-122 17 p. |
artikel |
8 |
Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients
|
Ikarashi, Yasushi |
|
2016 |
166 |
C |
p. 84-95 12 p. |
artikel |
9 |
Pharmacology of heart failure: From basic science to novel therapies
|
Lother, Achim |
|
2016 |
166 |
C |
p. 136-149 14 p. |
artikel |
10 |
Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer
|
De Pauw, I. |
|
2016 |
166 |
C |
p. 71-83 13 p. |
artikel |
11 |
Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
|
Delitto, Daniel |
|
2016 |
166 |
C |
p. 9-29 21 p. |
artikel |
12 |
The cytoskeleton as a novel target for treatment of renal fibrosis
|
Parrish, Alan R. |
|
2016 |
166 |
C |
p. 1-8 8 p. |
artikel |